MyHealthChecked (MHC) Competitors GBX 12.28 +0.53 (+4.47%) As of 07:03 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock MHC vs. POLX, IHC, AVO, RUA, SUN, BELL, DEMG, NIOX, SN, and MXCTShould you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Belluscura (BELL), Deltex Medical Group (DEMG), NIOX Group (NIOX), Smith & Nephew (SN), and MaxCyte (MXCT). These companies are all part of the "medical devices" industry. MyHealthChecked vs. Its Competitors Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences Surgical Innovations Group Belluscura Deltex Medical Group NIOX Group Smith & Nephew MaxCyte MyHealthChecked (LON:MHC) and Polarean Imaging (LON:POLX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, community ranking, earnings and risk. Do institutionals & insiders have more ownership in MHC or POLX? 3.1% of MyHealthChecked shares are owned by institutional investors. Comparatively, 12.1% of Polarean Imaging shares are owned by institutional investors. 53.6% of MyHealthChecked shares are owned by company insiders. Comparatively, 39.3% of Polarean Imaging shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media prefer MHC or POLX? In the previous week, MyHealthChecked had 1 more articles in the media than Polarean Imaging. MarketBeat recorded 1 mentions for MyHealthChecked and 0 mentions for Polarean Imaging. MyHealthChecked's average media sentiment score of 0.00 equaled Polarean Imaging'saverage media sentiment score. Company Overall Sentiment MyHealthChecked Neutral Polarean Imaging Neutral Which has more risk and volatility, MHC or POLX? MyHealthChecked has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Polarean Imaging has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Which has higher earnings and valuation, MHC or POLX? MyHealthChecked has higher revenue and earnings than Polarean Imaging. MyHealthChecked is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMyHealthChecked£9.43M0.68-£1.04M-£2.00-6.12Polarean Imaging£5.21M3.38-£69.44M-£3.89-0.31 Does the MarketBeat Community prefer MHC or POLX? Polarean Imaging received 23 more outperform votes than MyHealthChecked when rated by MarketBeat users. CompanyUnderperformOutperformMyHealthCheckedN/AN/APolarean ImagingOutperform Votes2367.65% Underperform Votes1132.35% Is MHC or POLX more profitable? MyHealthChecked has a net margin of -11.06% compared to Polarean Imaging's net margin of -1,333.97%. MyHealthChecked's return on equity of -12.80% beat Polarean Imaging's return on equity.Company Net Margins Return on Equity Return on Assets MyHealthChecked-11.06% -12.80% -8.18% Polarean Imaging -1,333.97%-86.11%-32.28% SummaryMyHealthChecked beats Polarean Imaging on 9 of the 13 factors compared between the two stocks. Get MyHealthChecked News Delivered to You Automatically Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MHC vs. The Competition Export to ExcelMetricMyHealthCheckedMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£6.39M£3.28B£5.61B£2.92BDividend YieldN/A2.44%5.28%4.90%P/E Ratio-6.1272.5327.14123.68Price / Sales0.68111.72414.30247,849.08Price / Cash1.7815.9938.2528.07Price / Book0.843.817.074.69Net Income-£1.04M£126.02M£3.23B£5.91B7 Day Performance8.87%-0.13%0.71%18.25%1 Month Performance2.29%10.60%9.65%22.35%1 Year Performance22.75%-4.57%32.07%77.85% MyHealthChecked Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MHCMyHealthCheckedN/AGBX 12.28+4.5%N/A+0.5%£6.39M£9.43M-6.1216Gap DownPOLXPolarean ImagingN/AGBX 1.37-0.7%N/A-19.7%£20.03M£5.21M-0.3528IHCInspiration Healthcare GroupN/AGBX 21.98+2.2%N/A+20.0%£19.04M£42.87M-1.51224Positive NewsGap UpAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.53-1.9%N/A+16.1%£7.16M£4.05M-2.6948SUNSurgical Innovations GroupN/AGBX 0.73+4.0%N/A+66.4%£6.79M£12.54M-21.1180BELLBelluscuraN/AGBX 0.79-1.4%N/A-92.5%£1.99M£2.87M-0.0824Gap UpDEMGDeltex Medical GroupN/AN/AN/AN/A£187K£1.76M-0.1537Gap UpHigh Trading VolumeNIOXNIOX GroupN/AGBX 71.40-1.9%GBX 90+26.1%-1.2%£29.33B£3.53B2,946.5592SNSmith & Nephew4.0364 of 5 starsGBX 1,082.50+0.0%GBX 7,840+624.2%+11.1%£11.87B£7.08B38.9718,452Positive NewsHigh Trading VolumeMXCTMaxCyteN/AGBX 166.50+0.6%N/A-57.0%£219.79M£57.52M-6.1080News CoverageNegative NewsGap Down Related Companies and Tools Related Companies Polarean Imaging Competitors Inspiration Healthcare Group Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors Surgical Innovations Group Competitors Belluscura Competitors Deltex Medical Group Competitors NIOX Group Competitors Smith & Nephew Competitors MaxCyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MHC) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyHealthChecked PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MyHealthChecked With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.